Literature DB >> 10702669

VPREB3: cDNA characterization and expression in human and chromosome mapping in human and mouse.

O Rosnet1, M G Mattéi, O Delattre, C Schiff.   

Abstract

The pre-B cell receptor (pre-BCR) regulates pre-B cell expansion and allelic exclusion at the immunoglobulin (Ig) heavy chain locus and mediates the selection of Ig heavy chain variable gene segments. During the early phase of pre-BCR assembly in the mouse, the membrane Ig mu heavy chain transiently associates with the VPREB3 protein in the endoplasmic reticulum. Here, we present the human VPREB3 cDNA sequence and its B cell-specific expression in hematopoietic cell lines. We have localized this gene to chromosome 22q11 close to IGLL genes in human and to chromosome 10C in mouse. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10702669     DOI: 10.1159/000015468

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  3 in total

1.  A VpreB3 homologue in a marsupial, the gray short-tailed opossum, Monodelphis domestica.

Authors:  Xinxin Wang; Zuly E Parra; Robert D Miller
Journal:  Immunogenetics       Date:  2012-06-09       Impact factor: 2.846

2.  Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.

Authors:  Saulo J A Felizola; Koshin Katsu; Kazue Ise; Yasuhiro Nakamura; Yoichi Arai; Fumitoshi Satoh; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

3.  The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.

Authors:  Scott J Rodig; Jeffery L Kutok; Jennifer C Paterson; Hiroaki Nitta; Wenjun Zhang; Bjoern Chapuy; Lynette K Tumwine; Santiago Montes-Moreno; Claudio Agostinelli; Nathalie A Johnson; Susana Ben-Neriah; Pedro Farinha; Margaret A Shipp; Miguel A Piris; Thomas M Grogan; Stefano A Pileri; Randy D Gascoyne; Teresa Marafioti
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.